PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES OF ASSOCIATES OF COPPER NANOPARTICLES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Abstract—The physicochemical parameters of associates of unstabilized copper nanoparticles (NPs) obtained by the plasma-chemical method were studied. Optical methods were used to determine the size of NP associates, including atomic force microscopy, spectrophotometry, and fluorometry. The sizes of copper NPs varied from 30 to 75 nm, and the sizes of NP associates, from 481.1 to 1037 nm. The phase composition of copper NPs was analyzed by X-ray diffractometry using a Rigaku Ultima IV multifunctional X-ray diffractometer. An oxide film without an admixture of organic molecules was found on the surface of NP associates. The effect of copper NPs on an A549 cell culture was studied. A change was observed in the biochemical parameters of blood serum of outbred mice under the influence of copper NPs. The antitumor effect of copper NPs was revealed, and its intensity was compared to different methods of administering NP to animals with fibrosarcoma (S-45) and Pliss lymphosarcoma.

About the authors

V. B. Borodulin

Saratov State Medical University, Russian Ministry of Health

Author for correspondence.
Email: borodulinvb@mail.ru
Russian Federation, Saratov

A. D. Matasov

Konstantinov St. Petersburg Institute of Nuclear Physics; Ioffe Institute

Email: borodulinvb@mail.ru
Russian Federation, St. Petersburg; St. Petersburg

I. A. Goroshinskaya

Rostov Research Institute of Oncology, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Rostov-on-Don

I. S. Okunev

Konstantinov St. Petersburg Institute of Nuclear Physics

Email: borodulinvb@mail.ru
Russian Federation, St. Petersburg

S. N. Petrov

Prometey

Email: borodulinvb@mail.ru
Russian Federation, St. Petersburg

N. F. Drozdova

Prometey

Email: borodulinvb@mail.ru
Russian Federation, St. Petersburg

P. S. Kachesova

Rostov Research Institute of Oncology, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Rostov-on-Don

O. E. Losev

Saratov State Medical University, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Saratov

E. V. Bobyleva

Saratov State Medical University, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Saratov

E. Yu. Zlatnik

Rostov Research Institute of Oncology, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Rostov-on-Don

E. G. Chebotareva

Saratov State Medical University, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Saratov

Ya. S. Lazarenko

Saratov State Medical University, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Saratov

A. V. Bobylev

Saratov State Medical University, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Saratov

E. V. Borodulina

Saratov State Medical University, Russian Ministry of Health

Email: borodulinvb@mail.ru
Russian Federation, Saratov

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Pleiades Publishing, Ltd.